Earnings, however, missed expectations. Alexza Pharmaceuticals Inc. (ALXA) said it initiated a 10-for-1 reverse stock split of its outstanding shares in an effort to regain compliance with Nasdaq and stay listed on the exchange. Career …
Mr. Colella served on the board of directors of Genomic Health, Inc. (NASDAQ: GHDX), a molecular diagnostics company, from 2001 to 2014; Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA), a pharmaceutical company, from 2001 to 2012; …
Schwartz said in a note late last year that a positive vote at a December advisory panel for Alexza Pharmaceuticals' (ALXA) inhaled drug Adasuve for ... the FDA's thinking on Levadex, however. The stock traded at $17.48 Friday morning.
Upon completion of the transaction Easterly will change its name to Sungevity Holdings, Inc. and will trade on the …
One biotechnology stock that looks like it has some new upward momentum on the stock market is Alexza Pharmaceuticals, Inc. (NASDAQ/ALXA). This biotechnology stock is way down from its previous highs, and there’s …
09/27 Carlisle Companies Incorporated upgraded by Zacks Investment Research to hold.. 09/25 Want the latest analyst …
BOSTON, March 26 (Reuters) - Alexza Pharmaceuticals Inc. ALXA.O reported positive clinical trial results for two of its experimental drugs on Monday, sending its shares soaring more than 48 percent. The Palo Alto, California-based …
Also, Classmates Media Corp., a subsidiary of United Online Inc. (UNTD), intends to raise up to $125 million via an initial public offering of its stock, according to a filing with the Securities and Exchange Commission. Alexza …
Biovail also recently struck a deal with Alexza Pharmaceuticals ALXA.O to develop and commercialize its inhaled treatment for agitation. Shares of Biovail were up 21 Canadian cents at C$15.58 on the Toronto Stock Exchange on …